10-Q
Quarterly Report
AIM IMMUNOTECH INC.
AIM
NYSEAMER
CIK: 946644
File #: 001-27072
Balance Sheet
36 line items · 2 periods
XBRL
| Item | Sep 30, 2024 | Dec 31, 2023 |
|---|---|---|
ASSETS | ||
Current assets: | ||
Cash and Cash Equivalents | 915,000 | 5,439,000 |
Cash and Cash Equivalents | 6,287,000 | 7,631,000 |
Accounts Receivable | — | 1,184,000 |
Other Non-Operating Current Assets | 368,000 | 302,000 |
Total current assets | 7,570,000 | 14,556,000 |
Property, Plant and Equipment | 117,000 | 127,000 |
Operating Lease Right-of-Use Asset | 653,000 | 697,000 |
Intangible Assets | 2,532,000 | 2,313,000 |
Patents | 2,428,000 | 2,197,000 |
Trademarks | 104,000 | 116,000 |
Other Non-Operating Non-Current Assets | 2,716,000 | 1,688,000 |
Total assets | 13,588,000 | 19,381,000 |
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
Current liabilities: | ||
Accounts Payable | 6,264,000 | 6,443,000 |
Other Current Liabilities | 1,011,000 | 1,986,000 |
Operating Lease Liability, Current | 232,000 | 223,000 |
Short-Term Debt | 2,593,000 | — |
Total current liabilities | 10,100,000 | 8,652,000 |
Long-term liabilities: | ||
Operating Lease Liability, Non-Current | 437,000 | 495,000 |
Long-Term Debt | 139,000 | — |
Total liabilities | 10,676,000 | 9,147,000 |
Stockholders’ equity: | ||
Series B Convertible Preferred Stock | — | 689,000 |
Total Stockholders' Equity | 59,000 | 49,000 |
Total Stockholders' Equity | 423,714,000 | 419,004,000 |
Total Stockholders' Equity | (420,861,000) | (409,508,000) |
Total stockholders’ equity | 2,912,000 | 10,234,000 |
Series B Preferred Stock - Preferred Stock | — | 689,000 |
Common Stock | 59,000 | 49,000 |
Additional Paid-in Capital | 423,714,000 | 419,004,000 |
Retained Earnings | (420,861,000) | (409,508,000) |
Total liabilities and stockholders’ equity | 13,588,000 | 19,381,000 |